| Recombinant t-PA in myocardial ischemia after switch operation. | |
| | |
MedLine Citation:
|
PMID: 15054563 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A well-recognized complication of the anatomic correction (arterial switch operation) of transposition of the great arteries is obstruction of the translocated coronary arteries. Myocardial reperfusion has previously been achieved by surgical revascularization or percutaneous balloon angioplasty. We report the case of a 3-month-old infant who suffered myocardial infarction 11 weeks after the arterial switch operation, in whom myocardial reperfusion was established following infusion of recombinant tissue-type plasminogen activator (Alteplase). |
| | |
Authors:
|
A Tzifa; U Joashi; Z Slavik |
Related Documents
:
|
2933943 - Applicability of laser to assist coronary balloon angioplasty. 16978993 - Facilitated percutaneous coronary intervention. 6984753 - Assessment of regional myocardial uptake and metabolism of omega-(p-123i-phenyl) pentad... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Pediatric cardiology Volume: 25 ISSN: 0172-0643 ISO Abbreviation: Pediatr Cardiol Publication Date: 2004 Jul-Aug |
Date Detail:
|
Created Date: 2004-10-19 Completed Date: 2005-09-08 Revised Date: 2008-02-20 |
Medline Journal Info:
|
Nlm Unique ID: 8003849 Medline TA: Pediatr Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 417-20 Citation Subset: IM |
Affiliation:
|
Department of Paediatric Intensive Care Unit, Royal Brompton Hospital, London, United Kingdom. aphrodite.tzifa@gsh.sthames.nhs.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary Coronary Angiography Echocardiography Heart Catheterization Humans Infant Male Myocardial Ischemia / diagnosis, drug therapy*, etiology Plasminogen Activators / therapeutic use* Postoperative Complications / diagnosis, drug therapy, etiology Tissue Plasminogen Activator / therapeutic use* Transposition of Great Vessels / therapy Ventricular Dysfunction, Left / diagnosis, drug therapy, etiology |
| Chemical | |
Reg. No./Substance:
|
EC 3.4.21.-/Plasminogen Activators; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Noninvasive ventilation for the management of pulmonary hypertension associated with congenital hear...
Next Document: Cardiac plasma cell granulomas: response to oral steroid treatment.